Skip Navigation


NDT Advance Access originally published online on September 27, 2005
Nephrology Dialysis Transplantation 2005 20(12):2681-2689; doi:10.1093/ndt/gfi136
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
20/12/2681    most recent
gfi136v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Patzak, A.
Right arrow Articles by Hocher, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patzak, A.
Right arrow Articles by Hocher, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2005]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org


Original Article

Angiotensin II sensitivity of afferent glomerular arterioles in endothelin-1 transgenic mice

Andreas Patzak1,2, Julia Bontscho1, EnYin Lai2, Eckehardt Kupsch3, Angela Skalweit1, Claus-Michael Richter4, Mathias Zimmermann4, Christa Thöne-Reineke4, Olaf Joehren5, Michael Godes4, Andreas Steege1 and Berthold Hocher4,6

1 Johannes-Müller-Institute of Physiology, University Hospital Charité, Humboldt-University of Berlin, Berlin, Germany, 2 Department of Medical Cell Biology, Division of Physiology, University of Uppsala, Uppsala, Sweden, 3 Institute of Pathology, Hospital Braunschweig, Braunschweig, Germany, 4 Center for Cardiovascular Research (CCR)/Department of Pharmacology and Toxicology, University Hospital Charité, Humboldt-University of Berlin, Berlin, Germany, 5 Institute of Experimental and Clinical Pharmacology and Toxicology, University of Luebeck, Luebeck, Germany, 6 Division of Nephrology and Hypertension, Inselspital, University of Berne, Berne, Switzerland

Correspondence and offprint requests to: Andreas Patzak, Johannes-Müller-Institut für Physiologie, Humboldt-Universität zu Berlin, Universitätsklinikum Charité, Tucholskystr. 2, 10117 Berlin. Email: andreas.patzak{at}charite.de

Background. Although endothelin I (ET-1) is a very potent vasoconstrictor, ET-1 transgenic (ET-1 tg) mice are not hypertensive. This might be due to higher bioavailability of nitric oxide (NO) in ET-1 tg, which counteracts the effect of vasoconstrictors. We hypothesized lower angiotensin II (Ang II) sensitivity of afferent arterioles in ET-1 tg.

Methods. Afferent arterioles were manually dissected and microperfused. Changes of the luminal diameter due to application of vasoactive substances were used for assessment of the reactivity of afferent arterioles. We investigated the effect of L-NAME, an unspecific NO synthase inhibitor, on basal tone, and the sensitivity of afferent arterioles to Ang II with and without pre-treatment with L-NAME. The renin-angiotensin-system was characterized by expression analysis of angiotensin-receptors and renin at the mRNA level.

Results. L-NAME reduced afferent arterioles diameters similarly in ET-1 tg and wild-types (WT). Ang II sensitivity determined by calculation of EC50 for Ang II was less in ET-1 tg compared with WT (P<0.05). Ang II reduced luminal diameters to a lesser extent in ET-1 tg compared to WT (P<0.05). After pre-treatment with L-NAME, Ang II sensitivity and maximum constriction of afferent arterioles were similar in ET-1 tg and WT. The expression of renin- and Ang II-receptor-mRNA in the kidney did not differ between either group.

Conclusion. The loss of differences in the maximum constriction and Ang II sensitivity of afferent arterioles between ET-1 tg and WT in the absence of NO suggests pronounced NO effects in afferent arterioles of ET-1 tg. This might contribute to the maintenance of normal renal arteriolar tone in ET-1 tg mice.

Keywords: afferent arteriole; angiotensin II; endothelin; ET-1 transgenic mouse; nitric oxide


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
J. E. Goodwin, J. Zhang, and D. S. Geller
A Critical Role for Vascular Smooth Muscle in Acute Glucocorticoid-Induced Hypertension
J. Am. Soc. Nephrol., July 1, 2008; 19(7): 1291 - 1299.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Patzak, A. Steege, E. Y. Lai, J. O. Brinkmann, E. Kupsch, N. Spielmann, A. Gericke, A. Skalweit, J. Stegbauer, P. B. Persson, et al.
Angiotensin II response in afferent arterioles of mice lacking either the endothelial or neuronal isoform of nitric oxide synthase
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R429 - R437.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
T. Quaschning, F. Voss, K. Relle, P. Kalk, N. Vignon-Zellweger, T. Pfab, C. Bauer, F. Theilig, S. Bachmann, A. Kraemer-Guth, et al.
Lack of Endothelial Nitric Oxide Synthase Promotes Endothelin-Induced Hypertension: Lessons from Endothelin-1 Transgenic/Endothelial Nitric Oxide Synthase Knockout Mice
J. Am. Soc. Nephrol., March 1, 2007; 18(3): 730 - 740.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.